Literature DB >> 24597564

Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling.

Aming Zhang1, Ping Hu, Paul MacGregor, Yu Xue, Haihong Fan, Peter Suchecki, Leonard Olszewski, Aston Liu.   

Abstract

Chemical modifications can potentially induce conformational changes near the modification site and thereby impact the safety and efficacy of protein therapeutics. Hydrogen/deuterium exchange mass spectrometry (HDX-MS) has emerged as a powerful analytical technique with high spatial resolution and sensitivity in detecting such local conformational changes. In this study, we utilized HDX-MS combined with structural modeling to examine the conformational impact on monoclonal antibodies (mAbs) caused by common chemical modifications including methionine (Met) oxidation, aspartic acid (Asp) isomerization, and asparagine (Asn) deamidation. Four mAbs with diverse sequences and glycosylation states were selected. The data suggested that the impact of Met oxidation was highly dependent on its location and glycosylation state. For mAbs with normal glycosylation in the Fc region, oxidation of the two conserved Met252 and Met428 (Kabat numbering) disrupted the interface interactions between the CH2 and CH3 domains, thus leading to a significant decrease in CH2 domain thermal stability as well as a slight increase in aggregation propensity. In contrast, Met oxidation in the variable region and CH3 domain had no detectable impact on mAb conformation. For aglycosylated mAb, Met oxidation could cause a more global conformational change to the whole CH2 domain, coincident with the larger decrease in thermal stability and significant increase in aggregation rate. Unlike Met oxidation, Asn deamidation and Asp isomerization mostly had very limited effects on mAb conformation, with the exception of succiminide intermediate formation which induced a measurable local conformational change to be more solvent protected. Structural modeling suggested that the succinimide intermediate was stabilized by adjacent aromatic amino acids through ring-ring stacking interactions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24597564     DOI: 10.1021/ac404130a

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  31 in total

1.  Conformational Assessment of Adnectin and Adnectin-Drug Conjugate by Hydrogen/Deuterium Exchange Mass Spectrometry.

Authors:  Richard Y-C Huang; Steven R O'Neil; Daša Lipovšek; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2018-05-07       Impact factor: 3.109

2.  Deciphering the Biophysical Effects of Oxidizing Sulfur-Containing Amino Acids in Interferon-beta-1a using MS and HDX-MS.

Authors:  Damian J Houde; George M Bou-Assaf; Steven A Berkowitz
Journal:  J Am Soc Mass Spectrom       Date:  2017-02-13       Impact factor: 3.109

3.  Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.

Authors:  Ranajoy Majumdar; Reza Esfandiary; Steven M Bishop; Hardeep S Samra; C Russell Middaugh; David B Volkin; David D Weis
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Conformational processing of oncogenic v-Src kinase by the molecular chaperone Hsp90.

Authors:  Edgar E Boczek; Lasse G Reefschläger; Marco Dehling; Tobias J Struller; Elisabeth Häusler; Andreas Seidl; Ville R I Kaila; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

Review 5.  Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.

Authors:  Ninad Varkhede; Rupesh Bommana; Christian Schöneich; M Laird Forrest
Journal:  J Pharm Sci       Date:  2019-08-10       Impact factor: 3.534

Review 6.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

7.  A Multidimensional Analytical Comparison of Remicade and the Biosimilar Remsima.

Authors:  Karthik Pisupati; Yuwei Tian; Solomon Okbazghi; Alexander Benet; Rose Ackermann; Michael Ford; Sergei Saveliev; Christopher M Hosfield; Marjeta Urh; Eric Carlson; Christopher Becker; Thomas J Tolbert; Steven P Schwendeman; Brandon T Ruotolo; Anna Schwendeman
Journal:  Anal Chem       Date:  2017-04-17       Impact factor: 6.986

8.  Characterization of Aggregation Propensity of a Human Fc-Fusion Protein Therapeutic by Hydrogen/Deuterium Exchange Mass Spectrometry.

Authors:  Richard Y-C Huang; Roxana E Iacob; Stanley R Krystek; Mi Jin; Hui Wei; Li Tao; Tapan K Das; Adrienne A Tymiak; John R Engen; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-15       Impact factor: 3.109

Review 9.  HDX-MS guided drug discovery: small molecules and biopharmaceuticals.

Authors:  David P Marciano; Venkatasubramanian Dharmarajan; Patrick R Griffin
Journal:  Curr Opin Struct Biol       Date:  2014-08-30       Impact factor: 6.809

10.  Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.

Authors:  Pamina Kazman; Marie-Theres Vielberg; María Daniela Pulido Cendales; Lioba Hunziger; Benedikt Weber; Ute Hegenbart; Martin Zacharias; Rolf Köhler; Stefan Schönland; Michael Groll; Johannes Buchner
Journal:  Elife       Date:  2020-03-10       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.